[Results of a multicenter study of Rebif-22 mcg administration in Russia].

The results of multicenter study of Rebif 22 micrograms in Russia have been reported. 167 multiple sclerosis patients have received Rebif 22 micrograms three times a week for 1 year. This study provides evidence for reduction of the relapse rate in patients with relapsing/remitting and secondary progressive multiple sclerosis.

[Differential diagnostic criteria of subarachnoid hemorrhage in arterial and arteriovenous aneurysms].

The clinical manifestations of subarachnoidal hemorrhages were investigated in 115 patients with arterial and 32 ones with arteriovenous aneurysms. The patients' histories, their neurologic status, the clinical and laboratory findings obtained were correlated, enabling the authors to specify the picture of subarachnoidal hemorrhages due to some congenital vascular pathology.